Microdisplay division sales decreased 11% in Q317 compared to Q217. Sales Revenue Split Q3 2017 Q2 2017 Q1 2017 Q4 2016 Q3 2016 PCBA (Lamphun, Thailand) 36% 39% 38% 38% 36% PCBA (Jiaxing, China) 16% 17% 18
compared to Q418. Sales Revenue Split Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 PCBA (Lamphun, Thailand) 44% 40% 38% 39% 43% PCBA (Jiaxing, China) 15% 17% 16% 18% 16% PCBA (Cambodia) 0% 0% 0% 0% 0% IC
Split Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 PCBA (Lamphun, Thailand) 44% 44% 40% 38% 39% PCBA (Jiaxing, China) 14% 15% 17% 16% 18% PCBA (Cambodia) 0% 0% 0% 0% 0% IC (Ayutthaya, Thailand) 32% 33% 34% 35
increasing by 1%. The Microdisplay division sales decreased 28% in Q118 compared to Q417. Sales Revenue Split Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017 PCBA (Lamphun, Thailand) 43% 39% 36% 39% 38% PCBA
with Ayutthaya sales increasing 14% and Jiaxing IC sales decreasing by 4%. The Microdisplay division sales increased 5% in Q218 compared to Q118. Sales Revenue Split Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2
Laboratories Co., Ltd. is a listed company established in the year 1971. The manufacture and distribution of conventional medicine. Office and Factory are located at No.47 Soi Boonchana, Sukhumvit 59, Klong Ton
increasing by 7%. The Microdisplay division sales decreased 10% in Q319 compared to Q219. Sales Revenue Split Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 PCBA (Lamphun, Thailand) 45% 44% 44% 40% 38% PCBA (Jiaxing
from split sites to ensure continuity of mission critical activities at not less than two buildings, in case one of the two sites must be closed or employees are ordered to self- quarantine. Adjust
decreasing 5% and Jiaxing IC sales decreasing by 34%. The Microdisplay division sales decreased 23% in Q120 compared to Q419. Sales Revenue Split Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 PCBA (Lamphun, Thailand
board. • RTO transactions are evenly split between distressed vs non- distressed firms and within industry vs between industry transactions. • Premiums received on new consolidated share price of